DexCom, Inc. (DXCM) vs Stryker Corporation (SYK)
- DexCom, Inc. DXCM 79.73 −5.60%
- Stryker Corporation SYK 324.50 −3.16%
DexCom, Inc. and Stryker Corporation are both Medical Devices companies. Stryker Corporation is the larger, with a market value of $127.6B against $31.5B — 4.0× the size. DexCom, Inc. trades at the lower P/E: 32.6× against 35.3×. DexCom, Inc. grew revenue faster over the last twelve months: 13.0% against 7.87%. DexCom, Inc. has the higher net margin (19.4% vs 13.8%) and the higher return on invested capital (39.0% vs 9.67%). Across the 22 metrics below, DexCom, Inc. leads on 15 and Stryker Corporation on 7.
Valuation
Profitability
| Metric | DXCM | SYK | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.42% | 65.34% | 57.76% |
| Operating margin | 23.98% | 20.66% | (15.07%) |
| Net margin | 19.41% | 13.78% | (14.45%) |
| Free cash flow margin | 21.52% | 16.76% | (3.88%) |
| Return on equity | 37.67% | 16.02% | (10.35%) |
| Return on assets | 14.43% | 7.68% | (17.26%) |
| Return on invested capital | 39.00% | 9.67% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack